<DOC>
	<DOCNO>NCT01060566</DOCNO>
	<brief_summary>The objective study evaluate effect VX-770 Midazolam Rosiglitazone , effect Fluconazole VX-770 .</brief_summary>
	<brief_title>Study VX-770 Midazolam Rosiglitazone Effect Fluconazole VX-770</brief_title>
	<detailed_description />
	<mesh_term>Cystic Fibrosis</mesh_term>
	<mesh_term>Fluconazole</mesh_term>
	<mesh_term>Rosiglitazone</mesh_term>
	<mesh_term>Midazolam</mesh_term>
	<criteria>Subjects must male female 18 55 year age . Subjects must judge good health . Subjects must body mass index ( BMI ) 18 30 kg/m2 . History illness , opinion investigator subject 's general practitioner , might confound result study pose additional risk administer study drug ( ) subject . Subjects human immunodeficiency virus ( HIV ) , hepatitis C , active hepatitis B . Female subject female partner ( ) male subject pregnant , nursing , plan become pregnant study within 90 day last dose study drug . History cardiovascular disease , hypoglycemia , edema .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2010</verification_date>
</DOC>